Ad is loading...
JEMWX
Price
$31.02
Change
-$0.24 (-0.77%)
Updated
Nov 15 closing price
RNWFX
Price
$80.56
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

JEMWX vs RNWFX

Header iconJEMWX vs RNWFX Comparison
Open Charts JEMWX vs RNWFXBanner chart's image
JPMorgan Emerging Markets Equity R6
Price$31.02
Change-$0.24 (-0.77%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$80.56
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
JEMWX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JEMWX vs. RNWFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JEMWX is a StrongSell and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.9B vs. JEMWX (6.96B). JEMWX pays higher dividends than RNWFX: JEMWX (1.63) vs RNWFX (1.51). JEMWX was incepted earlier than RNWFX: JEMWX (11 years) vs RNWFX (23 years). RNWFX is a more actively managed with annual turnover of: 32.00 vs. JEMWX (29.00). RNWFX has a lower initial minimum investment than JEMWX: RNWFX (250) vs JEMWX (15000000). RNWFX annual gain was more profitable for investors over the last year : 11.54 vs. JEMWX (9.16). RNWFX return over 5 years is better than : 17.17 vs. JEMWX (2.65).
JEMWXRNWFXJEMWX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years23 years-
Gain YTD4.5157.09964%
Front LoadN/AN/A-
Min. Initial Investment150000002506,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets6.96B60.9B11%
Annual Yield % from dividends1.631.51108%
Returns for 1 year9.1611.5479%
Returns for 3 years-25.88-14.55178%
Returns for 5 years2.6517.1715%
Returns for 10 years37.4141.0091%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRNA35.660.29
+0.82%
Verona Pharma plc
BURL268.94-0.65
-0.24%
Burlington Stores
RCMT22.25-0.38
-1.68%
RCM Technologies
SNTI2.15-0.18
-7.73%
Senti Biosciences Inc.
CATX7.88-1.04
-11.66%
Perspective Therapeutics